Pascal Bachelet News Today : Breaking News, Live Updates & Top Stories | Vimarsana

We read with great interest the EuroECMO-COVID study1 in The Lancet Respiratory Medicine. Roberto Lorusso and colleagues should be congratulated for this important research, which contributes to our understanding of the long-term outcomes of COVID-19 in the most severe forms of disease treated with extracorporeal membrane oxygenation (ECMO). However, we would like to draw attention to missing data that could have had a key role in lung recovery, extended ECMO duration, and associated complications.

Adverum Biotechnologies is cutting 78 jobs after announcing it had successfully amended its Investigational New Drug application for ADVM-022.to treat wet age-related macular degeneration.

Researchers said if patients get routine eye exams and compare them against the model used in this study, physicians could predict if someone will have a heart attack as soon as five years before it happens.

Researchers said if patients get routine eye exams and compare them against the model used in this study, physicians could predict if someone will have a heart attack as soon as five years before it happens.

Researchers said if patients get routine eye exams and compare them against the model used in this study, physicians could predict if someone will have a heart attack as soon as five years before it happens.